Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Nov 2013

Kessler Harald H, Hübner Margit, Konrad Petra M, Stelzl Evelyn, Stübler Madeleine M, Baser Merve H, Santner Brigitte I

Abstract excerpt

BACKGROUND: Accurate quantitation of hepatitis C virus (HCV) RNA is mandatory for the management of anti-HCV therapy. OBJECTIVES: The genotype-dependent performance of the new commercially available VERSANT HCV RNA 1.0 Assay (kPCR) and the COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, versi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepacivirus
Share to Hepatitis C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to RNA, Viral

Share to Sensitivity and Specificity

Share to Viral Load

Source

Identifiers

PMID: 24095028
DOI: 10.1016/j.jcv.2013.09.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24095028-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).PMID 24095028Read ↗

Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays.Semantic proximity Read ↗

Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.Semantic proximity Read ↗

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.Semantic proximity Read ↗

Differences between quantification of genotype 3 hepatitis C virus RNA by Versions 1.0 and 2.0 of the COBAS AmpliPrep/COBAS TaqMan HCV Test.Semantic proximity Read ↗

Comparison of cobas HCV GT against Versant HCV Genotype 2.0 (LiPA) with confirmation by Sanger sequencing.Semantic proximity Read ↗

Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.Semantic proximity Read ↗

Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.Semantic proximity Read ↗

Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.Semantic proximity Read ↗

Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.Semantic proximity Read ↗

The Cobas AmpliPrep/Cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNA.Semantic proximity Read ↗

Differences between two real-time PCR-based hepatitis C virus (HCV) assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and one signal amplification assay (Versant HCV RNA 3.0) for RNA detection and quantification.Semantic proximity Read ↗

Potential risk of misclassification HCV 2k/1b strains as HCV 2a/2c using VERSANT HCV Genotype 2.0 assay.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.